Irritable bowel syndrome: focus on otilonium bromide.

Abstract

Irritable bowel syndrome is a prevalent and chronic disorder, characterized by recurrent abdominal pain/discomfort, bloating and altered bowel habits. This condition affects an estimated 10-15% of the population worldwide and impacts heavily on a patient's daily life and ability to work, as well as healthcare resource utilization. Drug therapy aimed at… (More)
DOI: 10.1586/17474124.2014.869477

Topics

7 Figures and Tables

Slides referencing similar topics